Convergence: Using PREFER as a roadmap for patient preference studies
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesClinical TrialsEuropeGlobalNorth AmericaPharmaceuticalsRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesClinical TrialsEuropeGlobalNorth AmericaPharmaceuticals